Form D · Pharmaceuticals
Crossject SA
Dijon, I0 · CIK 0002136893
Offering snapshot reported Jun 5, 2026 · SEC filing
- Reported sold
- $0 Offering amount: $10.3M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 27, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 5, 2026 | Initial | $0 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-586322
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Maxim Group LLC | 120708 |
Source: Form D, filed Jun 5, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Patrick Alexandre | Director, Executive |
| Olivier Lacombe | Executive |
| Isabelle Liebschutz | Director, Executive |
| Didier Morin | Executive |
| Lionel Seltz | Executive |
| Tony Tipton | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
6 Rue Pauline Kergomard
Dijon, I0, 21000
Phone: 33 (0)3 80 54 98 50
Dijon, I0, 21000
Phone: 33 (0)3 80 54 98 50